MichaelJThorpyMD

PubMed

• Cataplexy response with extended-release once-nightly sodium oxybate: Post hoc responder analyses from the phase 3 REST-ON clinical trial.
  Richard Bogan, Bruce C Corser, Jennifer Gudeman, Michael J Thorpy, Clete A Kushida, Akinyemi O Ajayi> ;Sleep Medicine. 2024 Dec 1
• Brain fog in central disorders of hypersomnolence: a review.
  Russell Rosenberg, Michael J Thorpy, Karl Doghramji, Anne Marie Morse> ;Journal of Clinical Sleep Medicine. 2024 Apr 1
• Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
  Thomas Roth, Michael J Thorpy, Clete A Kushida, Matthew Horsnell, Jennifer Gudeman> ;Journal of Comparative Effectiveness Research. 2023 Dec 1
• 3 citations
  Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with...
  Anne Marie Morse, Yves Dauvilliers, Isabelle Arnulf, Michael J Thorpy, Nancy Foldvary-Schaefer, Patricia Chandler, Abby Chen, Luke Hickey, Jed Black, Richard K Bogan> ;Journal of Clinical Sleep Medicine. 2023 Oct 1
• 1 citations
  Efficacy of once-nightly sodium oxybate (FT218) in narcolepsy type 1 and type 2: post hoc analysis from the Phase 3 REST-ON Trial.
  Yves Dauvilliers, Thomas Roth, Richard Bogan, Michael J Thorpy, Anne Marie Morse, Asim Roy, Jordan Dubow, Jennifer Gudeman> ;Sleep. 2023 Nov 8
• Clinician Preferences for Oxybate Treatment for Narcolepsy: Survey and Discrete Choice Experiment.
  Anne Marie Morse, Lois Krahn, Julie Flygare, Clete Kushida, Michael J Thorpy, Amod Athavale, Jennifer Gudeman> ;Advances in Therapy. 2023 Jul 1
• 2 citations
  Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
  Richard K Bogan, Nancy Foldvary-Schaefer, Roman Skowronski, Abby Chen, Michael J Thorpy> ;CNS Drugs. 2023 Apr 1
• 15 citations
  Clinical considerations for the diagnosis of idiopathic hypersomnia.
  Yves Dauvilliers, Richard K Bogan, Isabelle Arnulf, Thomas E Scammell, Erik K St Louis, Michael J Thorpy> ;Sleep Medicine Reviews. 2022 Dec 1
• 2 citations
  Solriamfetol Titration & AdministRaTion (START) in Patients With Narcolepsy.
  Michael J Thorpy, Danielle Hyman, Gregory S Parks, Abby Chen, Catherine Foley, Beth Baldys, Diane Ito, Haramandeep Singh> ;Clinical Therapeutics. 2022 Oct 1
• 2 citations
  Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunt...
  Richard Bogan, Michael J Thorpy, John W Winkelman, Jordan Dubow, Jennifer Gudeman, David Seiden> ;Sleep Medicine. 2022 Dec 1
• 1 citations
  Solriamfetol Titration and AdministRaTion (START) in Patients with Obstructive Sleep Apnea: A Retrospective Chart Review and Hypothetical Patient Scenario.
  Haramandeep Singh, Danielle Hyman, Gregory S Parks, Abby Chen, Catherine Foley, Beth Baldys, Diane Ito, Michael J Thorpy> ;Advances in Therapy. 2022 Sep 1
• Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
  Yves Dauvilliers, Karel Šonka, Richard K Bogan, Markku Partinen, Rafael Del Rio Villegas, Nancy Foldvary-Schaefer, Roman Skowronski, Abby Chen, Jed Black, Franck Skobi...> ;CNS Drugs. 2022 Jul 1
• 6 citations
  Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
  Yves Dauvilliers, Karel Šonka, Richard K Bogan, Markku Partinen, Rafael Del Rio Villegas, Nancy Foldvary-Schaefer, Roman Skowronski, Abby Chen, Jed Black, Franck Skobi...> ;CNS Drugs. 2022 Jun 1
• 6 citations
  Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial.
  Thomas Roth, Yves Dauvilliers, Michael J Thorpy, Clete Kushida, Bruce C Corser, Richard Bogan, Russell Rosenberg, Jordan Dubow, David Seiden> ;CNS Drugs. 2022 Apr 1
• 4 citations
  Efficacy and Safety of Lower-Sodium Oxybate in an Open-Label Titration Period of a Phase 3 Clinical Study in Adults with Idiopathic Hypersomnia.
  Michael J Thorpy, Isabelle Arnulf, Nancy Foldvary-Schaefer, Anne Marie Morse, Karel Šonka, Patricia Chandler, Luke Hickey, Abby Chen, Jed Black, Amanda Sterkel, Dan Ch...> ;Nature and Science of Sleep. 2022 Jan 1
• 2 citations
  Current Understanding of Narcolepsy 1 and its Comorbidities: What Clinicians Need to Know.
  Lois E Krahn, Phyllis C Zee, Michael J Thorpy> ;Advances in Therapy. 2022 Jan 1
• 27 citations
  Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study.
  Yves Dauvilliers, Isabelle Arnulf, Nancy Foldvary-Schaefer, Anne Marie Morse, Karel Šonka, Michael J Thorpy, Emmanuel Mignot, Patricia Chandler, Rupa Parvataneni, Jed ...> ;The Lancet. Neurology. 2022 Jan 1
• 2 citations
  Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy.
  Yves Dauvilliers, Richard K Bogan, Karel Šonka, Markku Partinen, Nancy Foldvary-Schaefer, Michael J Thorpy> ;Nature and Science of Sleep. 2022 Jan 1
• 12 citations
  Corrigendum to: Efficacy and safety of calcium, magnesium, potassium, and sodium oxybates (lower-sodium oxybate [LXB]; JZP-258) in a placebo-controlled, double-blind, ...
  Richard K Bogan, Michael J Thorpy, Yves Dauvilliers, Markku Partinen, Rafael Del Rio Villegas, Nancy Foldvary-Schaefer, Roman Skowronski, Lihua Tang, Franck Skobierand...> ;Sleep. 2021 Nov 12
• 17 citations
  Once-Nightly Sodium Oxybate (FT218) Demonstrated Improvement of Symptoms in a Phase 3 Randomized Clinical Trial in Patients With Narcolepsy.
  Clete A. Kushida, Colin M. Shapiro, Thomas Roth, Michael J. Thorpy, Bruce C. Corser, Akinyemi Ajayi, Russell Rosenberg, Asim Roy, David Seiden, Jordan Dubow, Yves Dauv...> ;Sleep. 2021 Aug 6
• 3 citations
  Incidence and duration of common early-onset adverse events in randomized controlled trials of solriamfetol for treatment of excessive daytime sleepiness in obstructiv...
  Russell Rosenberg, Michael J. Thorpy, Yves Dauvilliers, Paula K. Schweitzer, Gary Zammit, Mark H. Gotfried, Shay Bujanover, Brian Scheckner, Atul Malhotra> ;Journal of Clinical Sleep Medicine. 2021 Jul 20
• 8 citations
  Corrigendum to: Efficacy and Safety of Calcium, Magnesium, Potassium, and Sodium Oxybates (Lower-Sodium Oxybate [LXB]; JZP-258) in a Placebo-Controlled, Double-Blind, ...
  Richard K Bogan, Michael J Thorpy, Yves Dauvilliers, Markku Partinen, Rafael Del Rio Villegas, Nancy Foldvary-Schaefer, Roman Skowronski, Lihua Tang, Franck Skobierand...> ;Sleep. 2021 Jul 9
• 2 citations
  Assessing the impact of sodium oxybate treatment on functioning, productivity, and health-related quality of life in patients with narcolepsy: findings from the Nexus ...
  Michael J. Thorpy, Maurice M. Ohayon, Ginger Carls, Jed Black, David J. Pasta, Danielle L Hyman, Kathleen F. Villa> ;Sleep Medicine. 2021 Jun 19
• 11 citations
  The Nexus Narcolepsy Registry: methodology, study population characteristics, and patterns and predictors of narcolepsy diagnosis.
  Maurice M. Ohayon, Michael J. Thorpy, Ginger Carls, Jed Black, Miriam G. Cisternas, David J. Pasta, Shay Bujanover, Danielle L Hyman, Kathleen F. Villa> ;Sleep Medicine. 2021 Jun 15
• 1 citations
  2018 worldwide survey of health-care providers caring for patients with narcolepsy: WSS narcolepsy task force.
  Leon Rosenthal, Michael J. Thorpy, Sona Nevsimalova, Geert Mayer, Fang Han, Yves Dauvilliers> ;Sleep Medicine. 2021 Mar 15
• Join now to see all